World's Best Scientists 2026 revealed!
Xiao-Jun Huang

Xiao-Jun Huang

D-Index & Metrics

Microbiology

D-Index
85
Citations
29793
World Ranking
866
National Ranking
22

Medicine

D-Index
86
Citations
32975
World Ranking
13958
National Ranking
158

Xiao-Jun Huang publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Xiao-Jun Huang sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 1,052 publications — 100th percentile

100% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Xiao-Jun Huang D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Xiao-Jun Huang sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 85 D-Index — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Xiao-Jun Huang is affiliated with Peking University in China and has contributed extensively to the field of medicine, with a strong focus on hematology. Their research portfolio comprises 1,126 publications, predominantly in hematology with 507 works, as well as substantial contributions to immunology, oncology, genetics, and public health.

The scientist's work revolves around several key topics, notably hematopoietic stem cell transplantation, acute myeloid leukemia research, and acute lymphoblastic leukemia research. Additional research interests include chronic myeloid leukemia treatments, immune cell function and interaction, T-cell and B-cell immunology, and chronic lymphocytic leukemia research.

Over their career, Xiao-Jun Huang has published frequently in several scientific journals and publication venues, with the most prolific appearances in:

  • Blood (44 publications)
  • PubMed (42 publications)
  • Bone Marrow Transplantation (36 publications)
  • Annals of Hematology (21 publications)
  • British Journal of Haematology (19 publications)

Notable recent papers by the scientist include:

  • "Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial" (2020) published in The Lancet Oncology
  • "The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update" (2021) published in Journal of Hematology & Oncology
  • "Treatment and unmet needs in steroid-refractory acute graft-versus-host disease" (2020) published in Leukemia
  • "Naturally Selected CD7 CAR-T Therapy without Genetic Manipulations for T-ALL/LBL: First-in-human Phase I Clinical Trial" (2022) published in Blood
  • "Antithymocyte Globulin for Matched Sibling Donor Transplantation in Patients With Hematologic Malignancies: A Multicenter, Open-Label, Randomized Controlled Study" (2020) published in Journal of Clinical Oncology

The scientist collaborates frequently with other researchers, including Lan-Ping Xu, Yu Wang, Xiaohui Zhang, Kai-Yan Liu, and Xiao-Dong Mo, each with numerous joint publications.

Best Publications

  • The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts

    Camille Abboud;Ellin Berman;Adam Cohen

  • Manganese Increases the Sensitivity of the cGAS-STING Pathway for Double-Stranded DNA and Is Required for the Host Defense against DNA Viruses

    Chenguang Wang;Yukun Guan;Mengze Lv;Rui Zhang

  • Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation.

    Dao Pei Lu;Lujia Dong;Lujia Dong;Tong Wu;Tong Wu;Xiao Jun Huang;Xiao Jun Huang

  • Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study.

    Yu Wang;Qi-Fa Liu;Lan-Ping Xu;Kai-Yan Liu

  • Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies

    Huang Xj;Liu Dh;Liu Ky;Xu Lp

  • Who is the best donor for a related HLA haplotype-mismatched transplant?

    Yu Wang;Ying-Jun Chang;Lan-Ping Xu;Kai-Yan Liu

  • Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation

    Xiao-Jun Huang;Dai-Hong Liu;Kai-Yan Liu;Lan-Ping Xu

  • MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trial

    Hong-Hu Zhu;Xiao-Hui Zhang;Ya-Zhen Qin;Dai-Hong Liu

  • Risk stratification-directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation

    Chen-Hua Yan;Dai-Hong Liu;Kai-Yan Liu;Lan-Ping Xu

  • The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China—recommendations from the Chinese Society of Hematology

    Lanping Xu;Hu Chen;Jing Chen;Mingzhe Han

  • Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial.

    Li Xuan;Yu Wang;Fen Huang;Zhiping Fan

  • Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia: nine years of experience at a single center.

    Yu Wang;Dai-Hong Liu;Kai-Yan Liu;Lan-Ping Xu

  • A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value.

    Wen-Lian Chen;Wen-Lian Chen;Jing-Han Wang;Ai-Hua Zhao;Xin Xu

  • Apoptotic Caspases Suppress Type I Interferon Production via the Cleavage of cGAS, MAVS, and IRF3

    Xiaohan Ning;Yutao Wang;Yutao Wang;Miao Jing;Miao Jing;Mengyin Sha;Mengyin Sha

  • The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update.

    Xiao-hui Zhang;Jing Chen;Ming-Zhe Han;He Huang

  • The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation.

    Stefan O. Ciurea;Kai Cao;Marcelo Fernadez-Vina;Piyanuch Kongtim

  • Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets.

    Ying-Jun Chang;Xiang-Yu Zhao;Lan-Ping Xu;Xiao-Hui Zhang

  • CD34+CD38+CD19+ as well as CD34+CD38−CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL

    Y Kong;S Yoshida;Y Saito;T Doi

  • Oral Tetra-Arsenic Tetra-Sulfide Formula Versus Intravenous Arsenic Trioxide As First-Line Treatment of Acute Promyelocytic Leukemia: A Multicenter Randomized Controlled Trial

    Hong-Hu Zhu;De-Pei Wu;Jie Jin;Jian-Yong Li

  • Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant.

    Lan-Ping Xu;Song Jin;Shun-Qing Wang;Ling-Hui Xia

  • Donor lymphocyte infusion for the treatment of leukemia relapse after HLA-mismatched/haploidentical T-cell-replete hematopoietic stem cell transplantation.

    Xiao-Jun Huang;Dai-Hong Liu;Kai-Yan Liu;Lan-Ping Xu

Frequent Co-Authors

Hao Jiang
Hao Jiang East China University of Science and Technology
He Huang
He Huang Zhejiang University
Arnon Nagler
Arnon Nagler Sheba Medical Center
Zhengfan Jiang
Zhengfan Jiang Peking University
Yangyuan Wang
Yangyuan Wang Peking University
Myriam Labopin
Myriam Labopin Université Paris Cité
Jing Wang
Jing Wang Chinese Academy of Sciences
Fabio Ciceri
Fabio Ciceri Vita-Salute San Raffaele University
Bipin N. Savani
Bipin N. Savani Vanderbilt University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to diverse career pathways, many of which intersect with the healthcare and information management fields. For those interested in the business side of healthcare, pursuing certifications like certified professional coder salary can provide a solid foundation in medical coding, an essential skill in managing patient data and billing processes.

Advanced degrees, such as a master in health information management salary, offer specialized knowledge and leadership opportunities in managing health data systems. These roles are increasingly vital as healthcare moves towards digital record-keeping and data analytics.

For students seeking flexible educational options, accredited programs such as online health information management degree programs cahiim accredited provide recognized credentials that meet industry standards. These programs ensure students gain relevant skills while balancing other commitments.

Additionally, quick entry into the field is possible through fast online medical billing and coding certification programs, which prepare students for certification exams and immediate employment in medical administrative roles. Combining microbiology studies with skills in health information management or medical coding can create a well-rounded career profile in the expanding healthcare sector.

Best Scientists Citing Xiao-Jun Huang

Trending Scientists

Recently Published Articles